Mitochondrial disease is genetic in the vast majority of cases. It can be caused by mutations in two different genomes: the DNA inside mitochondria themselves (mtDNA) or the nuclear DNA inherited from both parents. About one in 5,000 people carry disease-causing mitochondrial DNA mutations alone, and that number rises when nuclear DNA mutations are included.
What makes mitochondrial disease unusual, and sometimes confusing, is that “genetic” doesn’t always mean “inherited from a parent.” Roughly one in four cases involving mtDNA point mutations arise spontaneously, meaning neither parent carried the mutation. Understanding which genome is involved, and whether the mutation was inherited or new, changes everything about a family’s risk for future children.
Two Genomes, Two Inheritance Paths
Your cells contain two separate sets of DNA. The familiar one sits in the nucleus and holds 3.3 billion base pairs organized into chromosomes. The second is far smaller: a circular loop of just 16,569 base pairs tucked inside each mitochondrion. You have thousands of mitochondria per cell, each carrying its own copy of this mini-genome.
When a mitochondrial disease traces back to a mutation in the mitochondrial genome, it follows strict maternal inheritance. Mothers pass their mitochondria to all of their children; fathers contribute essentially none. After fertilization, the cell actively destroys paternal mitochondria using a specialized enzyme that breaks down the father’s mitochondrial DNA. This means a father with an mtDNA mutation will not pass it to any of his children, while a mother with one will pass it to all of hers.
When the disease traces back to a mutation in nuclear DNA, it follows the standard inheritance patterns you may already be familiar with. It can be autosomal recessive (both parents carry a silent copy and a child inherits two copies), autosomal dominant (one copy from one parent is enough to cause disease), or X-linked (carried on the X chromosome, typically affecting boys more severely). In adults with confirmed mitochondrial disease, nuclear DNA mutations account for roughly one-third of cases, with mtDNA mutations responsible for the remaining two-thirds.
Not Every Case Is Inherited
A significant portion of mtDNA mutations appear for the first time in a child without being present in the mother. In one well-studied series of 105 patients with disease-causing mtDNA point mutations, 24.6% were de novo, meaning they arose spontaneously. Children made up the majority of that de novo group, suggesting that newly appearing mutations may be an especially common explanation when mitochondrial disease shows up in childhood.
This distinction matters for families. If a mutation is confirmed as de novo (the mother’s tissues test negative), the chance of it appearing again in a future pregnancy is low. If the mutation was inherited, the mother will pass her mitochondrial DNA to every pregnancy, though the severity in each child can vary dramatically.
Why Severity Varies: The Threshold Effect
Each of your cells contains hundreds or thousands of copies of mitochondrial DNA. In many patients, some copies carry the mutation while others are normal. This mix is called heteroplasmy, and its ratio is the single biggest factor, alongside the type of mutation, in determining how sick someone gets.
A person needs to cross a biochemical threshold before symptoms appear. Depending on the mutation and the tissue involved, that threshold typically falls between 60% and 90% mutant copies. Someone carrying 40% mutant mitochondrial DNA in a given tissue might have no symptoms at all, while someone at 85% in the same tissue could be severely affected. Because mitochondrial DNA replicates independently of cell division, these percentages can shift over a person’s lifetime and differ between organs. That’s why mitochondrial disease often affects multiple body systems unevenly, and why a mother with mild or no symptoms can have a child who is much more seriously affected.
Common Mitochondrial Syndromes and Their Genes
Mitochondrial diseases aren’t one condition. They’re a family of disorders, and the specific gene involved shapes the symptoms. Leigh syndrome, one of the most common and severe forms in children, can result from mutations in dozens of different genes across both genomes. The most frequent cause is a deficiency in a key enzyme complex involved in energy production, often linked to X-linked mutations. A maternally inherited form of Leigh syndrome is commonly caused by a mutation in the gene encoding a component of the cell’s energy-producing machinery (the MT-ATP6 gene).
MELAS syndrome, which causes stroke-like episodes, seizures, and muscle weakness, is most often tied to a specific mutation in a mitochondrial gene involved in building proteins inside the mitochondrion. MERRF syndrome, characterized by seizures and muscle coordination problems, typically traces to a different mitochondrial gene mutation. Some of these mutations overlap: the same genetic change can produce features of more than one syndrome, which is part of what makes diagnosis challenging.
How Mitochondrial Disease Is Diagnosed Genetically
Genetic testing has become the primary diagnostic tool. The current standard approach uses whole exome sequencing, which reads the protein-coding portions of the nuclear genome. In practice, labs often filter the results through a virtual panel of genes already known to cause mitochondrial disease. If that panel comes back negative, the full exome data can be analyzed more broadly to look for unexpected causes. Mitochondrial DNA is typically sequenced separately, often from blood or muscle tissue, since heteroplasmy levels can differ between tissues.
Getting a definitive diagnosis often requires more than just a genetic test. Clinical features, brain imaging, metabolic markers, and biochemical testing of mitochondrial function in tissue samples all help a multidisciplinary team interpret the genetic findings. A variant in a gene doesn’t always mean disease; the clinical picture has to match.
Reproductive Options for Affected Families
For families with a known mtDNA mutation, reproductive planning hinges on the type of mutation and its inheritance pattern. Prenatal diagnosis can measure the level of a known mtDNA mutation in fetal tissue during pregnancy, giving families information about likely severity. Preimplantation genetic testing allows embryos created through IVF to be screened before transfer, selecting those with the lowest mutation levels.
For women who carry very high levels of a pathogenic mtDNA mutation, or whose mutation is homoplasmic (present in 100% of copies, making selection impossible), mitochondrial replacement therapy offers another path. This technique transfers the mother’s nuclear DNA into a donor egg that has healthy mitochondria, producing what’s sometimes called a “three-parent baby.” The child inherits nuclear DNA from both parents but mitochondrial DNA from the donor. This technology has been approved for clinical use in a small number of countries.
For nuclear DNA mutations, standard genetic counseling applies. Autosomal recessive mutations carry a 25% chance per pregnancy when both parents are carriers. Autosomal dominant mutations carry a 50% chance if one parent is affected. X-linked mutations follow the typical pattern where carrier mothers have a 50% chance of passing the variant to each child, with sons being affected and daughters becoming carriers who may or may not show symptoms.